King Michael bought SABS
February 21, 2024 · Form 4 insider transaction
King Michael bought 115,000 shares of SAB Biotherapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
115,000
Price
$0.00
Total value
N/A
InsiderKing Michael
RoleOfficer
SecurityEmployee Stock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateFebruary 21, 2024
Filing dateFebruary 23, 2024
Shares owned after115,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents options to purchase shares of common stock pursuant to the Company's 2014 Equity Incentive Plan.; The shares underlying the option vest over a four-year period, vesting 1/4 on the one-year anniversary of the date of grant, and the remaining 3/4 vesting pro rata on a monthly basis in 36 equal installments thereafter.